Pegfilgrastim
Drug timelines are a Plus or Pro feature.
65 regulatory and trial events tracked for Pegfilgrastim, covering 2008-02-28 to 2026-04-20. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label Prospective Study to Evaluate the Efficacy and Safety of Pegfilgrastim in Triple-Negative Breast Cancer Patients Receiving AC Regimen Following Paclitaxel and Carboplatin as Neoadjuvant Therapy [NA]